Disclosures for "Patient Journey in Status Epilepticus: Understanding Treatment Pathways, Outcomes, and Health Care Burden Using Patient Level Hospital Data"
-
Ms. Barra has nothing to disclose.
-
Mr. Saikumar has received personal compensation for serving as an employee of Trinity Life Sciences.
-
Mrs. Shah has nothing to disclose.
-
Mr. Katariya has received personal compensation for serving as an employee of Trinity Life Sciences.
-
Mrs. Lovink has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Trinity Life Sciences.
-
Dr. Vaitkevicius has received personal compensation for serving as an employee of Marinus Pharmaceuticals. Dr. Vaitkevicius has stock in Marinus Pharmaceuticals.
-
Dr. Rybak has received personal compensation for serving as an employee of Marinus Pharmaceuticals . Dr. Rybak has received stock or an ownership interest from Marinus Pharmaceuticals .